This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Vivesto Past Earnings Performance
Past criteria checks 0/6
Vivesto has been growing earnings at an average annual rate of 31.5%, while the Biotechs industry saw earnings growing at 29.1% annually. Revenues have been growing at an average rate of 64.6% per year.
Key information
31.49%
Earnings growth rate
35.23%
EPS growth rate
Biotechs Industry Growth
17.04%
Revenue growth rate
64.58%
Return on equity
-27.36%
Net Margin
n/a
Last Earnings Update
31 Dec 2025
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Vivesto makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:OASM.Y Revenue, expenses and earnings (SEK Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
0
-34
32
0
30 Sep 25
0
-36
32
0
30 Jun 25
0
-39
35
0
31 Mar 25
0
-40
36
0
31 Dec 24
0
-40
36
0
30 Sep 24
7
-93
52
0
30 Jun 24
7
-99
57
0
31 Mar 24
7
-117
73
0
31 Dec 23
7
-129
84
0
30 Sep 23
2
-284
88
0
30 Jun 23
3
-340
93
0
31 Mar 23
3
-351
95
0
31 Dec 22
3
-357
96
0
30 Sep 22
13
-140
101
0
30 Jun 22
24
-99
107
0
31 Mar 22
29
-118
111
0
31 Dec 21
29
-133
124
0
30 Sep 21
-184
-348
88
0
30 Jun 21
-195
-354
108
0
31 Mar 21
-199
-376
146
0
31 Dec 20
4
-210
185
0
31 Oct 20
205
-59
83
0
31 Jul 20
205
-24
73
0
30 Apr 20
206
-11
226
0
31 Jan 20
4
-196
113
0
31 Oct 19
6
-167
85
0
31 Jul 19
9
-210
60
0
30 Apr 19
10
-201
52
0
31 Jan 19
14
-154
107
0
31 Oct 18
13
-153
106
0
31 Jul 18
13
-117
106
0
30 Apr 18
12
-118
109
0
31 Jan 18
10
-128
115
0
31 Oct 17
10
-139
126
0
31 Jul 17
8
-155
135
0
30 Apr 17
7
-160
139
0
31 Jan 17
7
-151
139
0
31 Oct 16
16
-137
141
0
31 Jul 16
19
-139
148
0
30 Apr 16
23
-142
156
0
31 Jan 16
26
-139
150
0
31 Oct 15
18
-141
136
0
31 Jul 15
19
-124
122
0
30 Apr 15
19
-117
111
0
Quality Earnings: OASM.Y is currently unprofitable.
Growing Profit Margin: OASM.Y is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OASM.Y is unprofitable, but has reduced losses over the past 5 years at a rate of 31.5% per year.
Accelerating Growth: Unable to compare OASM.Y's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OASM.Y is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (50.1%).
Return on Equity
High ROE: OASM.Y has a negative Return on Equity (-27.36%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/04/28 16:22
End of Day Share Price
2026/02/10 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vivesto AB is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.